Vaxtex Cotfab Ltd (IN:VCL)
:VCL
Top Page
Vaxtex Cotfab Ltd
(VCL)
Select Model
Select Model
Rating:47Neutral
Price Target:
₹1.50
▼(-12.79% Downside)
Action:ReiteratedDate:03/14/26
The score is held down mainly by weak financial performance (sharp revenue drop and negative operating profitability) and bearish technicals (below key moving averages with negative MACD and oversold RSI). A very low P/E offers valuation support, but it does not outweigh the operational instability and current negative momentum.
Positive Factors
Manageable Leverage
A debt-to-equity of 0.61 indicates moderate leverage that preserves financial flexibility. Over the next 2-6 months this reduces refinancing and solvency risk, allowing the firm to absorb shocks, access working capital, and pursue restructuring or efficiency investments without immediate distress.
Negative Factors
Severe Revenue Decline
A 68.4% year-over-year revenue collapse signals structural demand loss or customer attrition. Such a steep fall erodes economies of scale, weakens supplier and customer relationships, and constrains pricing power. Without sustained revenue recovery, investments and profitability remain hard to restore.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable Leverage
A debt-to-equity of 0.61 indicates moderate leverage that preserves financial flexibility. Over the next 2-6 months this reduces refinancing and solvency risk, allowing the firm to absorb shocks, access working capital, and pursue restructuring or efficiency investments without immediate distress.
Read all positive factors
Vaxtex Cotfab Ltd (VCL) vs. iShares MSCI India ETF (INDA)
Market Cap
N/A
Dividend YieldN/A
Average Volume (3M)2.07M
Price to Earnings (P/E)2.4
Beta (1Y)1.09
Revenue Growth348.82%
EPS GrowthN/A
CountryIN
Employees36
SectorConsumer Defensive
Sector Strength42
IndustryApparel - Manufacturers
Share Statistics
EPS (TTM)0.21
Shares Outstanding183,752,210
10 Day Avg. Volume5,717,459
30 Day Avg. Volume2,074,626
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)0.73
Price to Sales (P/S)2.55
P/FCF Ratio11.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Vaxtex Cotfab Ltd Business Overview & Revenue Model
Company Description
Vaxtex Cotfab Limited manufactures textiles. The company offers denim fabrics, home textile, jeans, men's casual shirts, printed fabrics, and yarns. It offers shirting fabrics to various international brands, export houses, corporate buyers, domes...
How the Company Makes Money
Vaxtex Cotfab Ltd generates revenue through the sale of its textile products, including dyed and printed fabrics, to both domestic and international customers. Income is derived from its manufacturing operations, where it transforms raw materials ...
Vaxtex Cotfab Ltd Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
57
Neutral
Cash Flow
65
Positive
| Breakdown | TTM | Mar 2025 | Jun 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 75.40M | 52.53M | 166.20M | 756.22M | 619.07M | 261.54M |
| Gross Profit | -1.69M | 78.00K | -52.45M | 53.06M | 77.76M | 26.91M |
| EBITDA | 11.98M | 6.28M | -86.16M | 20.68M | 33.85M | 14.98M |
| Net Income | 15.00M | 8.84M | -88.34M | 11.32M | 14.86M | 1.78M |
Balance Sheet | ||||||
| Total Assets | 457.05M | 484.74M | 488.72M | 694.85M | 239.88M | 216.86M |
| Cash, Cash Equivalents and Short-Term Investments | 12.48M | 11.84M | 11.24M | 11.21M | 11.23M | 1.14M |
| Total Debt | 109.25M | 111.29M | 115.17M | 51.92M | 74.53M | 102.94M |
| Total Liabilities | 283.86M | 301.33M | 300.81M | 460.02M | 136.29M | 128.12M |
| Stockholders Equity | 173.19M | 183.40M | 187.91M | 234.82M | 103.59M | 88.74M |
Cash Flow | ||||||
| Free Cash Flow | -8.75M | 11.62M | -131.36M | -118.79M | 18.16M | -6.90M |
| Operating Cash Flow | -8.75M | 11.62M | -131.36M | -118.56M | 21.73M | 9.32M |
| Investing Cash Flow | 15.34M | -7.60M | -31.78M | 3.37M | -10.63M | 23.99M |
| Financing Cash Flow | -6.37M | -4.19M | 162.43M | 105.05M | -30.08M | -34.10M |
Vaxtex Cotfab Ltd Technical Analysis
Positive
1.72
Price Trends
1.82
Negative
1.88
Negative
1.45
Positive
Market Momentum
-0.13
Negative
46.02
Neutral
88.89
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VCL, the sentiment is Positive. The current price of 1.72 is above the 20-day moving average (MA) of 1.45, below the 50-day MA of 1.82, and above the 200-day MA of 1.45, indicating a neutral trend. The MACD of -0.13 indicates Negative momentum. The RSI at 46.02 is Neutral, neither overbought nor oversold. The STOCH value of 88.89 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:VCL.
Vaxtex Cotfab Ltd Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
47 Neutral | ― | 2.39 | ― | ― | 348.82% | ― | |
43 Neutral | ₹130.37M | -3.16 | ― | ― | -53.77% | ― | |
43 Neutral | ₹20.22M | -25.42 | ― | ― | ― | ― |
* Consumer Defensive Sector Average
IN:VCL
Vaxtex Cotfab Ltd
1.51
0.75
98.68%
IN:ABHISHEK
Mahaalaxmi Texpro Limited
―
―
―
IN:EUROTEXIND
Eurotex Industries & Exports Ltd.
14.90
1.90
14.62%
IN:GANGOTRI
Gangotri Textiles Limited
0.62
-0.42
-40.38%
IN:RAJVIR
Rajvir Industries Limited
9.20
-5.15
-35.89%
Vaxtex Cotfab Ltd Corporate Events
Vaxtex Cotfab Files EGM Scrutinizer’s Report and Voting Results with NSE
Mar 3, 2026
Vaxtex Cotfab Limited has submitted to the National Stock Exchange the scrutinizer’s report and voting results for its Extraordinary General Meeting held on February 27, 2026. The meeting was conducted via video conferencing and other audio-...
Vaxtex Cotfab Plans Major Capital Expansion, Governance Changes Ahead of February EGM
Jan 20, 2026
Vaxtex Cotfab’s board has approved a major increase in its authorised share capital from ₹19 crore to ₹500 crore and plans to amend its Memorandum of Association accordingly, signalling preparations for substantial future equity ...
Vaxtex Cotfab Plans Major Capital Expansion and Strategic Overhaul
Jan 20, 2026
Vaxtex Cotfab Limited’s board has approved a significant expansion of its financial and corporate framework, proposing to increase its authorised share capital from ₹19 crore to ₹500 crore and raising its limits for investments, ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.